# | Title | Journal | Year | Citations |
---|
1 | Effects of Attention and Emotion on Face Processing in the Human Brain | Neuron | 2001 | 1,508 |
2 | Neuroimaging Evidence for Dissociable Forms of Repetition Priming | Science | 2000 | 583 |
3 | Mitochondrial disease | Lancet, The | 2006 | 561 |
4 | Explaining modulation of reasoning by belief | Cognition | 2003 | 403 |
5 | Platelet mitochondria function in Parkinson's disease | Annals of Neurology | 1992 | 337 |
6 | Mitochondrial respiratory chain disorders I: mitochondrial DNA defects | Lancet, The | 2000 | 320 |
7 | Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia | Annals of Neurology | 1992 | 263 |
8 | Neuroprotection in Parkinson Disease | JAMA - Journal of the American Medical Association | 2004 | 258 |
9 | The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse | Clinical Neurophysiology | 2004 | 215 |
10 | Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy | Diabetes | 1997 | 211 |
11 | The interaction between mood and cognitive function studied with PET | Psychological Medicine | 1997 | 202 |
12 | Continuous dopamine-receptor stimulation in early Parkinson's disease | Trends in Neurosciences | 2000 | 185 |
13 | Ventromedial prefrontal cortex mediates guessing | Neuropsychologia | 1999 | 184 |
14 | Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects | Lancet, The | 2000 | 183 |
15 | The variability of intracortical inhibition and facilitation | Clinical Neurophysiology | 2003 | 175 |
16 | Waking up to sleep episodes in Parkinson's Disease | Movement Disorders | 2000 | 163 |
17 | Science, medicine, and the future: Parkinson's disease | BMJ: British Medical Journal | 1999 | 151 |
18 | Sleep attacks (sleep episodes) with pergolide | Lancet, The | 2000 | 146 |
19 | Oxidative-phosphorylation defects in liver of patients with Wilson's disease | Lancet, The | 2000 | 130 |
20 | Hemispheric specialization for global and local processing: the effect of stimulus category | Proceedings of the Royal Society B: Biological Sciences | 1997 | 127 |
21 | Why have we failed to achieve neuroprotection in Parkinson's disease? | Annals of Neurology | 2008 | 125 |
22 | The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease | Movement Disorders | 2013 | 121 |
23 | Cholinergic Modulation of Experience-Dependent Plasticity in Human Auditory Cortex | Neuron | 2002 | 120 |
24 | Adaptive anterior hippocampal responses to oddball stimuli | Hippocampus | 2001 | 103 |
25 | A clinical and family history study of Parkinson's disease in heterozygousglucocerebrosidasemutation carriers | Journal of Neurology, Neurosurgery and Psychiatry | 2012 | 99 |
26 | Neuroprotection and dopamine agonists | Neurology | 2002 | 75 |
27 | Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome | Clinical Neurophysiology | 2005 | 74 |
28 | A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus | QJM - Monthly Journal of the Association of Physicians | 2002 | 71 |
29 | Friedreich's Ataxia: From Disease Mechanisms to Therapeutic Interventions | Antioxidants and Redox Signaling | 2006 | 71 |
30 | Abnormal neural integration related to cognition in schizophrenia | Acta Psychiatrica Scandinavica | 1999 | 69 |
31 | Angiopoietin-2 Is a Site-Specific Factor in Differentiation of Mouse Renal Vasculature | Journal of the American Society of Nephrology: JASN | 2000 | 66 |
32 | Deletions of chromosome 17p11.2 in multifocal neuropathies | Annals of Neurology | 1996 | 62 |
33 | Primary and secondary defects of the mitochondrial respiratory chain | Journal of Inherited Metabolic Disease | 2002 | 59 |
34 | Free radicals and mitochondrial dysfunction in Parkinson's disease | Biochemical Society Transactions | 1993 | 39 |
35 | The Influence of Eye Colour upon Temporary Threshold Shift | International Journal of Audiology | 1976 | 37 |
36 | Caffeine has no effect on measures of cortical excitability | Clinical Neurophysiology | 2005 | 37 |
37 | HMPAO SPET does not distinguish obsessive–compulsive and tic syndromes in families multiply affected with Gilles de la Tourette's syndrome | Psychological Medicine | 1997 | 35 |
38 | Diagnosing restless legs syndrome (RLS) in primary care | Current Medical Research and Opinion | 2004 | 32 |
39 | The functional anatomy of memory | Experientia | 1995 | 29 |
40 | Neuroprotection in PD—A role for dopamine agonists? | Neurology | 2003 | 28 |
41 | The Neural Response in Short-Term Visual Recognition Memory for Perceptual Conjunctions | NeuroImage | 1998 | 24 |
42 | The "new" mitochondrial disorders | Journal of Neurology, Neurosurgery and Psychiatry | 2002 | 22 |
43 | Inborn and Induced Defects of Mitochondria | Archives of Neurology | 1998 | 19 |
44 | Diabetic Neuropathy | Drugs | 1986 | 16 |
45 | The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease | Neurology | 2000 | 15 |
46 | Patterns of brain activity in patients with epilepsy and depression | Seizure: the Journal of the British Epilepsy Association | 1999 | 9 |
47 | Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation | Acta Neuropathologica | 2013 | 9 |
48 | Mitochondria in the etiology of Parkinson's disease | Handbook of Clinical Neurology / Edited By P J Vinken and G W Bruyn | 2007 | 7 |
49 | Polypeptide and glycoprotein abnormalities in dorsal root ganglia of streptozotocin-diabetic rats | Journal of the Neurological Sciences | 1989 | 1 |
50 | First-line Treatment in Parkinson’s Disease | Practical Neurology | 2005 | 1 |